The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...

Glucocorticoids: As little as prednisone 2.5 mg daily or the equivalent for at least 3 months is associated with decreases in BMD and increased osteoporosis ... long-term drug effects are ...

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

Amgen’s osteoporosis bone-forming drug Evenity (romosozumab) has been approved in Japan, ahead of a crunch review by advisers to the US regulator later this month. Evenity could have been on the ...

Dailymotion Concerns over popular osteoporosis drug side effects Posted: 31 October 2024 | Last updated: 3 November 2024 Patients are raising concerns about a lack of informed consent over the ...

Patients have told ABC NEWS they're concerned about a lack of informed consent over Australia's most common osteoporosis drug and are sometimes "scared into" taking it. Doctors acknowledge Prolia ...

They say not enough of them are being adequately informed of side effects or complications when coming-off the drug. Patients are raising concerns about a lack of informed consent over the nation ...

Add videos to your saved list and come back to them any time.

While osteoporosis is much more common in adults over age 60, it can strike younger people too. In fact, according to the ...